NCT04762069Phase 2Active not recruiting

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Study sponsor: CNS Pharmaceuticals, Inc. · CNSP

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04-27Estimated
Enrollment · participants252Actual
Source updated2026-04-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 210 participants (planned). After: 252 participants (actual).

Primary completion date changed

Before: 1 Feb 2026. After: 27 Apr 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview